Trial Information

Summary: Females with diarrhea-predominant Irritable Bowel Syndrome (IBS): A 16 week, randomized, placebo-controlled study to assess the Safety of different doses of an investigational medication.

Screening period of 2 weeks

• Physical examination, blood tests and assessment of IBS.
• Questionnaires
• Colonoscopy if not done within 2 years of screening

Baseline

• Clinical Assessments
• Start oral medication
• Start daily self rating of IBS pain/discomfort symptoms /ul>

  Visit at 4 and 16 weeks

  • Clinical Assessments
  • Blood Sample
  • Start daily self rating of IBS pain/discomfort symptoms

  Inclusion Criteria: 18 years or older, female with diagnosis of IBS for at least 6 months and have failed conventional therapy.

  Exclusion Criteria: History of constipation, gastroparesis, GI malignancy's, diverticulitis or other Gastrointestinal diseases or conditions. Laxitive abuse. Pregnant or lactating females.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:43:37 AM